Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06996600 · ClinicalTrials.gov registry record · NA
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
A NA study of Hydrocephalus, sponsored by Rhaeos.
- Recruiting
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT06996600: Recruiting NA study of Hydrocephalus, sponsored by Rhaeos.
NCT06996600 is a NA study of Hydrocephalus that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 29 participants, below the 132-participant average among 17 other Hydrocephalus trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06996600, a NA study of Hydrocephalus, is actively recruiting participants, sponsored by Rhaeos.
- RECRUITING
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during headache and non-headache periods.
Primary Outcome
Exploratory analysis to determine the relationship between headaches (subject-reported headache and non-headache periods) and measured flow. Data will be analyzed using the Point-Biserial Correlation Coefficient between headaches periods (headache and non-headache periods) and thermal flow score (flow score derived from algorithm analysis of raw thermal data)
Conditions Studied
Interventions
- DEVICE wireless thermal anisotropy measurement device
Study Locations (1)
Illinois
- Rhaeos, Inc - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2025-05-02 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06996600 shows while recruiting
NCT06996600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 132-participant average among 17 other Hydrocephalus trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which wireless thermal anisotropy measurement device is the first listed.
NCT06996600 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06996600 about?
NCT06996600 is a clinical study titled "Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device". This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during headache and non-headache periods.
What is the current status of trial NCT06996600?
This trial is currently recruiting. It is a NA study. The enrollment target is 29 participants. The study started on 2025-05-02. Estimated completion is 2025-12.
What conditions does trial NCT06996600 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT06996600?
The interventions under investigation include: wireless thermal anisotropy measurement device (DEVICE).
Who is sponsoring clinical trial NCT06996600?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06996600 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06996600's enrollment target sits among peer trials
29 16th of 17 higher than 2 of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
-
Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
RECRUITING · NA
-
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
RECRUITING · NA
-
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI